Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
8 min read
ADAMTS14 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAMTS14, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAMTS13 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAMTS13, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAMTS12 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAMTS12, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAMTS10 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAMTS10, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAMTS9 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAMTS9, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAMTS8 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAMTS8, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAMTS7 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAMTS7, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAMTS6 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAMTS6, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAMTS4 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAMTS4, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAMTS3 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAMTS3, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAMTS2 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAMTS2, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAMTS1 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAMTS1, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.